Polynucleotides
US12331331B2 · kind B2 · utility
0Cited by
6References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2020 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | Feb 18, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y302/01045
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to polynucleotides comprising a GBA nucleotide sequence that encodes a GCase protein or fragment thereof and wherein a portion of the coding sequence is not wild type. The present invention further relates to viral particles comprising a recombinant genome comprising the polynucleotide of the invention, compositions comprising the polynucleotides or viral particles, and methods and uses of the polynucleotides, viral particles or compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.